Lifetime Comorbidity of DSM-IV Mood and Anxiety Disorders and Specific Drug Use Disorders: Results From the National Epidemiologic Survey on Alcohol and Related Conditions
The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To present nationally representative data on the lifetime prevalence and comorbidity of 8 specific drug use disorders, separately for abuse and dependence, and mood and anxiety disorders. METHOD: Data come from a representative sample (N=43,093) of the United States civilian, noninstitutional population 18 years and older. Diagnoses of mood, anxiety, and drug use disorders were based upon face-to-face personal interviews using the Alcohol Use Disorder and Associated Disabilities Interview Schedule-DSM-IV Version (AUDADIS-IV). RESULTS: Associations between specific mood and anxiety disorders and specific drug use disorders were virtually all positive and statistically significant (p<.05). In general, associations were greater for dependence than abuse, greater for mood than anxiety disorders, and in some instances stronger among women than men (p<.05). Large odds ratios also were observed for individuals with comorbid mood and anxiety disorders. CONCLUSION: The comorbidity between specific mood and anxiety disorders and specific drug use disorders is pervasive in the U.S. population. Findings suggest that comorbid psychiatric disorders may increase the risk of greater involvement in more serious illicit drug use disorders and that the greater comorbidity between mood and anxiety and drug use disorders among women may reflect greater deviance and psychopathology among drug-using women than men. Findings also suggest that drug abuse prevention and intervention efforts should address other psychiatric conditions. Further, definitions of drug use disorder phenotypes should give careful consideration to other psychiatric conditions as meaningful characteristics of case heterogeneity.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Anxiety disorders are highly comorbid with substance use disorders [43]”
From Correlates of Quality of Life in Anxiety Disorders: Review of Recent Research (2021) · cites this paper as [43]
In the citing paper
“relapse for SUD, experience increased distress, internalized stigma, lower quality of life, and a higher likelihood of using multiple substances than people diagnosed with SUD alone(Carpentier et al., 2009; Chang et al., 2019; Conway et al., 2006; Lejuez et al., 2008; Rogers et al., 2019).”
From A systematic review and meta-analysis of psychosocial interventions for persons with comorbid anxiety and substance use disorders (2024) · cites this paper as Conway et al., 2006
In the citing paper
“GAD, PD, agoraphobia, social phobia, and specific phobias are often found to be highly co-morbid with each other as well as other psychiatric disorders including depression, PTSD, and substance-use disorders (Conway et al, 2006;Kaufman and Charney, 2000;Regier et al, 1998).”
From Inflammation in Fear- and Anxiety-Based Disorders: PTSD, GAD, and Beyond (2017) · cites this paper as Conway et al, 2006
In the citing paper
“Furthermore, gambling disorder frequently co-occurs with substance use disorders, particularly alcohol and nicotine, as well as mood and anxiety disorders (Conway, Compton, Stinson, & Grant, 2006; B. F. Grant et al., 2004b; Petry et al., 2005; Ronzitti, Kraus, Hoff, & Potenza, 2018).”
From Cued for Risk: Evidence for an Incentive Sensitization Framework to Explain the Interplay between Stress and Anxiety, Substance Abuse, and Reward Uncertainty in Disordered Gambling Behavior (2019) · cites this paper as Conway, Compton, Stinson, & Grant, 2006
Citations
Cites
Kessler, R. C., Berglund, P., Demler, O., Jin, R., Merikangas, K. R., & Walters, E. E. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.6.593 · Cited by 20,391
Regier, D. A. (1990) · JAMA · doi:10.1001/jama.1990.03450190043026 · Cited by 3,962
Smoking and Mental Illness: A Population-Based Prevalence Study
Lasser, K., Boyd, J. W., Woolhandler, S., Himmelstein, D. U., McCormick, D., & Bor, D. H. (2000) · JAMA · doi:10.1001/jama.284.20.2606 · Cited by 2,508
Kessler, R. C. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830160031005 · Cited by 2,085
Kessler, R. C., Nelson, C. B., McGonagle, K. A., Edlund, M. J., Frank, R. G., & Leaf, P. J. (1996) · American Journal of Orthopsychiatry · doi:10.1037/h0080151 · Cited by 1,378
Grant, B. F., Dawson, D. A., Stinson, F. S., Chou, P. S., Kay, W., & Pickering, R. (2003) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(03)00070-x · Cited by 1,110
Self-citationHelzer, J. E., & Pryzbeck, T. R. (1988) · Journal of Studies on Alcohol · doi:10.15288/jsa.1988.49.219 · Cited by 1,081
Comorbidity of substance use disorders with mood and anxiety disorders
Merikangas, K. R., Mehta, R. L., Molnar, B. E., Walters, E. E., Swendsen, J. D., Aguilar-Gaziola, S., Bijl, R., Borges, G., Caraveo-Anduaga, J. J., Dewit, D. J., et al. (1998) · Addictive Behaviors · doi:10.1016/s0306-4603(98)00076-8 · Cited by 725
Grant, B. (1995) · Drug and Alcohol Dependence · doi:10.1016/0376-8716(95)01134-k · Cited by 686
Self-citationGrant, B. F., Stinson, F. S., Dawson, D. A., Chou, S. P., Ruan, W. J., & Pickering, R. P. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.4.361 · Cited by 644
Self-citation
Cited by
Items 301–400 of 933
Zainul‐Abidin, S., Amanatullah, D. F., Anderson, M. B., Austin, M. S., Barretto, J. M., Battenberg, A. K., Bedard, N. A., Bell, K., Blevins, K. M., Callaghan, J. J., et al. (2018) · The Journal of Arthroplasty · doi:10.1016/j.arth.2018.09.050 · Cited by 29
Li, J., Wang, H., Li, M., Shen, Q., Li, X., Rong, X., & Peng, Y. (2020) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13437 · Cited by 30
Neuroimmune Mechanisms and Sex/Gender-Dependent Effects in the Pathophysiology of Mental Disorders
Kokkosis, A. G., & Tsirka, S. E. (2020) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.120.266163 · Cited by 34
Lorenzo, R. D., Galliani, A., Ferri, P., Landi, G., & Guicciardi, A. (2014) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s65896 · Cited by 38
Reddon, H., Pettes, T., Wood, E., Nosova, E., Milloy, M., Kerr, T. H., & Hayashi, K. (2017) · Drug and Alcohol Review · doi:10.1111/dar.12631 · Cited by 37
“[27] Conway KP, Compton W, Stinson FS, Grant BF.”
BackgroundLowder, E. M., Lawson, S. G., O’Donnell, D., Sightes, E., & Ray, B. R. (2020) · Criminology & Public Policy · doi:10.1111/1745-9133.12509 · Cited by 31
Dunbar, E. K., Saloman, J. L., Phillips, A. E., & Whitcomb, D. C. (2021) · Journal of Pain Research · doi:10.2147/jpr.s274276 · Cited by 30
Gatta, E., Camussi, D., Auta, J., Guidotti, A., & Pandey, S. C. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108299 · Cited by 30
Sex differences in addiction-relevant behavioral outcomes in rodents following early life stress
Rincón‐Cortés, M. (2023) · Addiction Neuroscience · doi:10.1016/j.addicn.2023.100067 · Cited by 27
Koob, G. F., Kandel, D. B., Baler, R., & Volkow, N. D. (2023) · Springer eBooks · doi:10.1007/978-3-030-42825-9_29-1 · Cited by 42
Pilowsky, D. J., Wu, L.-T. T., Burchett, B., Blazer, D. G., WOODY, G. E., & Ling, W. (2011) · Substance Abuse and Rehabilitation · doi:10.2147/sar.s20895 · Cited by 30
“Overall, these results reveal a high prevalence of depression, anxiety, and suicidal thoughts/attempts among current amphetamine users.(9,24,54) While a higher prevalence of hallucinations among current amphetamine noninjectors than nonusers is consistent with other research,(21,22) it did not remain significant after…”
Ehlers, C. L., Gilder, D. A., Gizer, I. R., & Wilhelmsen, K. C. (2009) · Addiction Biology · doi:10.1111/j.1369-1600.2009.00160.x · Cited by 28
“…drug dependence, but also with anxiety, depression and personality disorders (Regier et al. 1990; Troisi et al. 1998; Agosti, Nunes & Levin 2002; Conway et al. 2006; Stinson et al. 2006), suggesting that cannabis dependence shares etiological relationships with other substance use and…”
InfluentialFactors associated with Medicaid patients' access to buprenorphine treatment
Baxter, J. D., Clark, R. E., Samnaliev, M., Leung, G. Y., & Hashemi, L. (2011) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2011.02.002 · Cited by 31
Biologic Commonalities between Mental Illness and Addiction.
Hartwell, K. J., Tolliver, B. K., & Brady, K. T. (2009) · PubMed · Cited by 31
Alloy, L. B., Abramson, L. Y., Flynn, M. E., Liu, R. T., Grant, D. A., Jager‐Hyman, S., & Whitehouse, W. G. (2009) · International Journal of Cognitive Therapy · doi:10.1521/ijct.2009.2.4.354 · Cited by 30
What’s deficient in reward deficiency?
Leyton, M. (2014) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.140204 · Cited by 33
Examining the Relationship between Social Connection and Opioid Misuse: A Systematic Review
Cance, J. D., Saavedra, L. M., Wondimu, B. B., Scaglione, N. M., Hairgrove, S., & Graham, P. (2021) · Substance Use & Misuse · doi:10.1080/10826084.2021.1936056 · Cited by 32
“…how social connection—defined broadly as the subjective sense of belonging—is associated with substance use outcomes as an upstream variable is a necessary next step in developing prevention- and treatment-based knowledge (Blanco et al., 2020; Conway et al., 2006; Magidson et al., 2012).”
BackgroundIsbell, L. M., Chimowitz, H., Huff, N. R., Liu, G., Kimball, E. W., & Boudreaux, E. D. (2023) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2022.10.014 · Cited by 47
Pleil, K. E., & Skelly, M. J. (2018) · Alcohol · doi:10.1016/j.alcohol.2018.01.007 · Cited by 29
“Women are more likely than men to have anxiety and mood disorders, as well as comorbid alcohol/substance abuse disorders (Back, 2011; Breslau, 2001; Conway, 2006; Kessler, Chiu, Demler, Merikangas, & Walters, 2005; Steiner et al., 2005; Wilcox & Yates, 1993).”
BackgroundHser, Y., Zhu, Y., Fei, Z., Mooney, L. J., Evans, E., Kelleghan, A. R., Matthews, A. G., Yoo, C. K., & Saxon, A. J. (2021) · Addiction · doi:10.1111/add.15594 · Cited by 28
“INTRODUCTION Mental disorders among individuals with opioid use disorder (OUD) are common [1,2].”
BackgroundMediating processes between stress and problematic marijuana use
Ketcherside, A., & Filbey, F. M. (2015) · Addictive Behaviors · doi:10.1016/j.addbeh.2015.01.015 · Cited by 38
Brief alcohol screening in a clinical psychiatric population: Special attention needed
Nehlin, C., Fredriksson, A., & Jansson, L. (2011) · Drug and Alcohol Review · doi:10.1111/j.1465-3362.2011.00333.x · Cited by 30
“The lifetime risk of an addictive disorder is more than twice as high among persons with a mental disorder, for some subgroups even considerably higher [1–4].”
BackgroundLee, J. H., Gamarel, K. E., Kahler, C. W., Marshall, B. D. L., van den Berg, J. J., BRYANT, K. J., Zaller, N. D., & Operario, D. (2015) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2015.03.018 · Cited by 32
Goode, T. D., Kim, J., & Maren, S. (2015) · eNeuro · doi:10.1523/eneuro.0037-15.2015 · Cited by 29
Singh, N., Ghayour‐Minaie, M., Skvarc, D., & Toumbourou, J. W. (2019) · Journal of Youth and Adolescence · doi:10.1007/s10964-019-00992-6 · Cited by 39
Wallin, C. M., Bowen, S. E., & Brummelte, S. (2021) · Neurotoxicology and Teratology · doi:10.1016/j.ntt.2021.106976 · Cited by 27
Zhang, Y., Xu, Z., Zhang, S., Desrosiers, A., Schottenfeld, R. S., & Chawarski, M. C. (2014) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2014.02.010 · Cited by 27
“Repeated and extensive use of ATS may cause psychotic symptoms and is associated with mood disorders (Glasner-Edwards et al., 2008; Kalechstein et al., 2000; Zweben et al., 2004) and anxiety disorders (Conway et al., 2006).”
BackgroundBao, Y., Qiu, Y., Yan, S., Jia, Z., Li, S., Lian, Z., Mu, Y., & Liu, Z. (2013) · PLoS ONE · doi:10.1371/journal.pone.0060544 · Cited by 30
“Some studies showed that the prevalence of depression ranged from 28%-80% among ATS users or ATS dependent patients seeking treatment [9,10,19,20].”
BackgroundPreoperative Evaluation of the Patient with Substance Use Disorder and Perioperative Considerations
Pulley, D. D. (2016) · Anesthesiology Clinics · doi:10.1016/j.anclin.2015.10.015 · Cited by 27
“There isevidenceofanassociationbetweenspecificdrugusedisordersandmoodand anxiety disorders.(6) It is not clear what the exact mechanism is, but it has been proposed that drugs of abuse cause symptoms that mimic other mental illnesses, other mental illnesses can lead todrug abuse, or drugabuse/othermental illnesses sha…”
Mental health disorders among homeless, substance‐dependent men who have sex with men
Fletcher, J. B., & Reback, C. J. (2016) · Drug and Alcohol Review · doi:10.1111/dar.12446 · Cited by 26
“Among thosewith a drug dependency, anxiety andmood disorder prevalence is significantly increased [1].”
BackgroundSwain, J. E., & Ho, S.-H. S. (2019) · Journal of Neuroendocrinology · doi:10.1111/jne.12770 · Cited by 28
Subtyping of substance use disorders in a high-risk welfare-to-work sample: A latent class analysis
Schwartz, B., Wetzler, S. E., Swanson, A. J., & Sung, S. C. (2010) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2010.03.001 · Cited by 26
Psychiatric Comorbidity and Acculturation Stress Among Puerto Rican Substance Abusers
Conway, K. P., Swendsen, J. D., Dierker, L., CANINO, G. J., & Merikangas, K. R. (2007) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2007.02.033 · Cited by 31
Self-citationHealth service utilization of heroin abusers: A retrospective cohort study
Chen, I., Huang, C. L.-C., Yeh, B.-J., & Chien, Y. (2015) · Addictive Behaviors · doi:10.1016/j.addbeh.2015.01.042 · Cited by 24
Goulet-Stock, S., Rueda, S., Vafaei, A., Ialomiteanu, A., Manthey, J., Rehm, J. T., & Fischer, B. (2017) · European Addiction Research · doi:10.1159/000475987 · Cited by 28
Alamir, Y. A., Zullig, K. J., Wen, S., Montgomery‐Downs, H. E., Kristjánsson, Á. L., Misra, R., & Zhang, J. (2017) · Behavioral Sleep Medicine · doi:10.1080/15402002.2017.1403325 · Cited by 30
Characteristics and correlates of fentanyl preferences among people with opioid use disorder
Hochstatter, K. R., Terplan, M., Mitchell, S. G., Schwartz, R. P., Dušek, K., Wireman, K., & Gryczynski, J. (2022) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2022.109630 · Cited by 30
Miguel, A. C., Madruga, C. S., Cogo‐Moreira, H., Yamauchi, R., Simões, V., Ribeiro, A., da Silva, C. J., Fruci, A., McDonell, M. G., McPherson, S., et al. (2017) · Experimental and Clinical Psychopharmacology · doi:10.1037/pha0000147 · Cited by 30
“As has previously been reported (Conway et al., 2006; Falck et al., 2002; Kiluk et al., 2013), we found depressive and anxiety symptoms to be common among crack cocaine users, with mean BDI-II and BAI scores considered moderate.”
BackgroundGunn, R. L., Stevens, A. K., Micalizzi, L., Jackson, K. M., Borsari, B. E., & Metrik, J. (2020) · Experimental and Clinical Psychopharmacology · doi:10.1037/pha0000357 · Cited by 28
“…suggest that cannabis use may lead to later increased symptoms of depression, there is also robust evidence for the opposite direction of effects (Agosti et al., 2002; Conway et al., 2006) as well as absence of a longitudinal relationship between cannabis use and depression (Blanco et al., 2016).”
BackgroundMemedovic, S., Slade, T., Ross, J., Darke, S., Mills, K. L., Marel, C., Burns, L., Lynskey, M., & Teesson, M. (2019) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2019.05.028 · Cited by 24
Carter, J. S., Kearns, A., Vollmer, K. M., García‐Keller, C., Weber, R. A., Baker, N. L., Kalivas, P. W., & Reichel, C. M. (2020) · Psychopharmacology · doi:10.1007/s00213-020-05486-z · Cited by 25
“Individuals with stress or anxiety disorders are particularly vulnerable to opioid abuse (Conway et al. 2006), and a diagnosis of post-traumatic stress disorder (PTSD) substantially increases the probability of developing substance use disorders (SUDs).”
Wolitzky-Taylor, K. B. (2023) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2023.110990 · Cited by 33
Krystal, J. H., Gueorguieva, R. V., Cramer, J. A., Collins, J. F., Rosenheck, R. A., & The VA CSP No. 425 Study Team (2007) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2007.00555.x · Cited by 25
Drugs of abuse and addiction: A slippery slope toward liver injury
Roy, D. N., & Goswami, R. (2015) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2015.09.018 · Cited by 29
“and abuse of alcohol, opiates, stimulants and sedatives [18, 19].”
BackgroundCarter, R. E., Haynes, L. F., Back, S. E., Herrin, A. E., Brady, K. T., Leimberger, J., Sonne, S. C., Hubbard, R. L., & Liepman, M. R. (2007) · The American Journal of Drug and Alcohol Abuse · doi:10.1080/00952990701764599 · Cited by 26
“With regard to comorbid psychiatric diagnoses among individuals with substance use disorders, women typically have higher rates (9, 10), and the association between mood=anxiety disorders and comorbid substance use disorders appears to be stronger for women than men (7).”
BackgroundResultMental Illness and Substance Use Disorders among Women Veterans with Diabetes
Banerjea, R., POGACH, L. M., Smelson, D. A., & Sambamoorthi, U. (2009) · Women s Health Issues · doi:10.1016/j.whi.2009.07.007 · Cited by 24
Nunes, E. J., Bitner, L. E., Hughley, S. M., Small, K. M., Walton, S. N., Rupprecht, L. E., & Addy, N. (2019) · Neuroscience · doi:10.1016/j.neuroscience.2019.06.028 · Cited by 29
“Drug addiction is also often comorbid with mood-related disorders, including depression and anxiety (Conway et al., 2006).”
BackgroundBidirectional relationship between heroin addiction and depression: Behavioural and neural studies
Moustafa, A. A., Tindle, R., Cashel, S., Parkes, D., Mohamed, E., & Hamza, E. A. (2020) · Current Psychology · doi:10.1007/s12144-020-01032-4 · Cited by 32
“Drug addiction is a chronic medical condition that is associated with significant psychopathology (Conway et al. 2006; Goodwin et al. 2002; Kessler et al. 1994; Tindle et al. 2020).”
BackgroundPatterns of psychological distress related to regular methamphetamine and opioid use
Darke, S. G., Torok, M. H., McKetin, R., Kaye, S. S., & Ross, J. E. (2011) · Addiction Research & Theory · doi:10.3109/16066351003695631 · Cited by 25
“Previous studies have examined the relationship between diagnoses of substance dependence and comorbid diagnoses, and of levels of individual substance use with the severity of pathology (Conway et al., 2006; Dalmau et al., 1999; Farrell et al., 2002; McKetin et al., 2006; Nakama et al., 2008).”
BackgroundGoldstein, R. B., Dawson, D. A., Stinson, F. S., Ruan, W. J., Chou, S. P., Pickering, R. P., & Grant, B. F. (2007) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2007.10.005 · Cited by 25
“Reliability and validity of AUDADIS-IV diagnoses and tobacco, alcohol, and drug consumption measures—As reported in detail elsewhere [71], reliability and validity were good to excellent for all substance use disorders [1,60,73-80], and fair to good for mood, anxiety, and personality disorders, including ASPD [1,7,9,5…”
BackgroundSelf-citationDixon, L. J., Lee, A. A., Gratz, K. L., & Tull, M. T. (2018) · Journal of Anxiety Disorders · doi:10.1016/j.janxdis.2017.10.009 · Cited by 23
“In particular, rates of anxiety disorders among individuals with SUD have been found to range from 17.7–29.9% in epidemiological studies (Conway et al., 2006; Grant et al., 2004) and from 26.4–38.8% in SUD treatment samples (Franken & Hendriks, 2001; McGovern, Xie, Segal, Siembab, & Drake, 2006).”
BackgroundInfluentialKetamine’s potential as a rapid antidepressant was overplayed
Zhang, M. W., & Ho, R. (2015) · BMJ · doi:10.1136/bmj.h4467 · Cited by 24
Ngo, H., Tait, R. J., & Hulse, G. K. (2010) · Journal of Psychopharmacology · doi:10.1177/0269881110364266 · Cited by 25
“Among opioid abusers, comorbidities of depression, anxiety, and personality disorders are most common (Strain, 2002), with a lifetime prevalence of mood, anxiety, or personality disorders as high as 73%, 61%, and 65%, respectively (Conway et al., 2006; Darke et al., 1998).”
BackgroundPeck, K. R., Schumacher, J. A., Stasiewicz, P. R., & Coffey, S. F. (2018) · Journal of Traumatic Stress · doi:10.1002/jts.22291 · Cited by 26
Roberge, P., Provencher, M. D., Gosselin, P., Vasiliadis, H., Gaboury, I., Benoît, A., Antony, M. M., Chaillet, N., Houle, J., Hudon, C., et al. (2018) · BMC Psychiatry · doi:10.1186/s12888-018-1898-1 · Cited by 34
Bart, C. P., Titone, M. K., Ng, T. H., Nusslock, R., & Alloy, L. B. (2021) · Clinical Psychology Review · doi:10.1016/j.cpr.2021.102035 · Cited by 35
“Thus, it is not surprising that these two disorders frequently co-occur (Conway, Compton, Stinson, & Grant, 2006); SUDs are present in over a third of people diagnosed with BSDs (Merikangas et al., 2011).”
Ross, J. E., Teesson, M., Lejuez, C. W., Mills, K. L., Kaye, S. S., Brady, K. T., Dore, G., Prior, K., Larkin, X., Cassar, J., et al. (2016) · BMC Psychiatry · doi:10.1186/s12888-016-0943-1 · Cited by 30
“Background The frequent co-occurrence of depression and substance use disorders (SUDs) is well documented both in Australia and internationally [1–9], with epidemiological studies suggesting that affective disorders are up to 4.”
BackgroundChen, Y., Zhang, J., & Sun, Y. (2019) · International Journal of Clinical and Health Psychology · doi:10.1016/j.ijchp.2019.06.003 · Cited by 28
Why do liver transplant patients so often become obese? The addiction transfer hypothesis
Brunault, P., Salamé, E., Jaafari, N., Courtois, R., Réveillère, C., Silvain, C., Benyamina, A., Blecha, L., Belin, D., & Ballon, N. (2015) · Medical Hypotheses · doi:10.1016/j.mehy.2015.03.026 · Cited by 22
“These risk factors might include certain executive dysfunctions that are shared between binge eating and binge drinking, such as impaired cognitive flexibility or shifting attention [40,41] and some psychiatric comorbidities such as mood disorders, anxiety disorders [42,43], and attention deficit hyperactivity disorde…”
BackgroundSmiley, C. E., & Wood, S. K. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108212 · Cited by 25
McEachin, R. C., Chen, H., Sartor, M. A., Saccone, S. F., Keller, B. J., Prossin, A. R., Cavalcoli, J. D., & McInnis, M. G. (2010) · BMC Systems Biology · doi:10.1186/1752-0509-4-158 · Cited by 22
“between FOS and NR4A2 with respect to the keyword “cocaine”, we used NESARC (the National Epidemiological Survey of Alcohol and Related Conditions) [23], a population based survey of 43,093 subjects, to assess rates of comorbid BD and cocaine abuse.”
MethodWu, Q., Chen, T., Wang, Z., Chen, S., Zhang, J., Bao, J., Su, H., Tan, H., Jiang, H., Du, J., et al. (2019) · Substance Abuse · doi:10.1080/08897077.2019.1675117 · Cited by 22
“A majority of patients with SUD, including MA-dependent patients, experience negative emotions, especially depression and anxiety.(18,19) Research found that negative emotions weaken treatment motivation.”
BackgroundMoeller, S. J., Platt, J. M., Wu, M., & Goodwin, R. D. (2020) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2020.107895 · Cited by 30
“The reliability and validity of the AUDADIS-IV are well documented in numerous national and international psychometric studies conducted in clinical and general populations, the latter being for whom it was designed (Blanco et al., 2008; Conway et al., 2006; Cranford et al., 2011; Delforterie et al., 2015; Elliott et…”
BackgroundNusslock, R., Alloy, L. B., Ly, A., Harmon‐Jones, E., & Me, H. (2008) · PubMed · Cited by 28
Gunn, R. L., Jackson, K. M., Borsari, B. E., & Metrik, J. (2018) · Borderline Personality Disorder and Emotion Dysregulation · doi:10.1186/s40479-018-0087-7 · Cited by 27
“In contrast, large epidemiological studies have also revealed MDD was prospectively associated with CUD and contributed to its etiology [24, 25].”
ResultDemographic and psychiatric correlates of compulsive sexual behaviors in gambling disorder
Cowie, M. E., Kim, H. S., Hodgins, D. C., McGrath, D. S., Scanavino, M. D. T., & Tavares, H. (2019) · Journal of Behavioral Addictions · doi:10.1556/2006.8.2019.35 · Cited by 21
“Moreover, independent investigations of individuals with GD and individuals with CSBs reveal similar co-occurring conditions, with mood, anxiety, and SUDs being the most frequent comorbidities for both GD and CSBs (Lorains et al., 2011; Raymond et al., 2003).”
BackgroundInfluentialDiagnostic profiles of offenders in substance abuse treatment programs
Grella, C. E., Greenwell, L., PRENDERGAST, M. L., Sacks, S., & Melnick, G. (2008) · Behavioral Sciences & the Law · doi:10.1002/bsl.825 · Cited by 23
Spears, C. A., Jones, D. M., Weaver, S. R., Pechacek, T. F., & Eriksen, M. P. (2018) · Addictive Behaviors · doi:10.1016/j.addbeh.2018.01.014 · Cited by 22
Ethical Issues in Emergency Psychiatry
Allen, N. G., Khan, J. S., Alzahri, M. S., & Stolar, A. (2015) · Emergency Medicine Clinics of North America · doi:10.1016/j.emc.2015.07.012 · Cited by 21
Rubio, G., Manzanares, J., Jiménez, M., Rodrigues-Jimenez, R., Martínez, I. M., Iribarren, M. M., Jiménez‐Arriero, M. Á., Ponce, G., & Palomo, T. (2008) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v69n0407 · Cited by 21
Divin, A. L., & Zullig, K. J. (2014) · AIMS Public Health · doi:10.3934/publichealth.2014.4.226 · Cited by 22
“NMPDU has also been associated with a variety of psychopathologies including depression [6,10–14] and suicidal behavior [10,15,16].”
Kilbourne, A. M., Greenwald, D., Hermann, R. C., Charns, M. P., McCarthy, J. F., & Yano, E. M. (2009) · Psychiatric Services · doi:10.1176/ps.2010.61.1.38 · Cited by 23
Dong, H., Yang, M., Liu, L., Zhang, C., Liu, M., Shen, Y., Liu, H., & Hao, W. (2017) · BMC Psychiatry · doi:10.1186/s12888-017-1346-7 · Cited by 21
Wolitzky-Taylor, K. B., & Schiffman, J. E. (2019) · Journal of Dual Diagnosis · doi:10.1080/15504263.2019.1589660 · Cited by 19
Bahí, A., & Dreyer, J. (2019) · Psychopharmacology · doi:10.1007/s00213-019-05408-8 · Cited by 22
Strickland, J. C., Stoops, W. W., Banks, M. L., & Gipson, C. D. (2022) · Journal of the Experimental Analysis of Behavior · doi:10.1002/jeab.757 · Cited by 25
Comer, J. S., Gallo, K. P., Korathu-Larson, P. A., Pincus, D. B., & Brown, T. A. (2012) · Depression and Anxiety · doi:10.1002/da.21981 · Cited by 21
“[6] Children with ADs are at elevated risk for the development of depression, sleep disturbance, peer dysfunction, and substance use[7–10] When left untreated, childhood anxiety can persist into adulthood, during which time it is associated with the presence of other psychiatric conditions,[1, 11, 12] physical comorbi…”
BackgroundZhang, J., Xie, Y., Su, H., Tao, J., Sun, Y., Li, L., Liang, H., He, R., Han, B., Lu, Y., et al. (2014) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2014.06.021 · Cited by 22
“6% of amphetamine adult users (Conway et al., 2006).”
Three-Year Course of Cannabis Dependence and Prediction of Persistence
van der Pol, P., Liebregts, N., de Graaf, R., Korf, D. J., van den Brink, W., & van Laar, M. (2015) · European Addiction Research · doi:10.1159/000377625 · Cited by 24
Arslan, G. (2023) · Journal of Ethnicity in Substance Abuse · doi:10.1080/15332640.2023.2237930 · Cited by 25
“Individuals with psychological disorders such as depression, post-traumatic stress disorder, or personality disorders are more likely to use drugs (Arslan, 2022; Conway et al., 2006; Moitra et al., 2013; Witkiewitz & Villarroel, 2009).”
Odenwald, M. G., & Semrau, P. (2011) · European Addiction Research · doi:10.1159/000333336 · Cited by 23
Roy, É., Jutras‐Aswad, D., Bertrand, K., Dufour, M., Perreault, M., Laverdière, É., Tchaleu, F. B., & Bruneau, J. (2015) · American Journal on Addictions · doi:10.1111/ajad.12286 · Cited by 20
Moreno, D. H., & Andrade, L. H. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2009.09.023 · Cited by 20
“, predominance of female gender and being 35– 54 years old, and married (Conway et al., 2006; Goodwin and Jamison, 2007; Mitchell et al., 2008).”
BackgroundFrohlich, J. R., Rapinda, K. K., Schaub, M. P., Wenger, A., Baumgartner, C., Johnson, E. A., O’Connor, R. M., Vincent, N., Blankers, M., Ebert, D. D., et al. (2018) · JMIR Research Protocols · doi:10.2196/11298 · Cited by 24
Agoglia, A. E., Crofton, E. J., & Herman, M. A. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.108045 · Cited by 21
“Patients with anxiety disorders such as post-traumatic stress disorder (PTSD) are more likely to develop AUD than the general population, but this relationship is stronger in women than in men (Conway et al., 2006).”
BackgroundLooming threat-processing style in a cancer cohort
Levin, T. T., Riskind, J. H., & Li, Y. (2006) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2006.10.005 · Cited by 20
“26) [12].”
Prayer: A Helpful Aid in Recovery from Depression
Johnson, K. A. (2018) · Journal of Religion and Health · doi:10.1007/s10943-018-0564-8 · Cited by 24
The Mental Health of U.S. Parents During the COVID-19 Pandemic
Lamar, M. R., Speciale, M., Forbes, L. K., & Donovan, C. (2021) · Journal of Mental Health Counseling · doi:10.17744/mehc.43.4.03 · Cited by 20
Efrati, Y., Goldman, K., Levin, K., & Rosca, P. (2022) · Addictive Behaviors · doi:10.1016/j.addbeh.2022.107379 · Cited by 22
Tkaczynski, J. A., Borodovitsyna, O., & Chandler, D. J. (2022) · Brain Sciences · doi:10.3390/brainsci12070860 · Cited by 19
“Indeed, opioid use disorder and anxiety disorders are frequently comorbid [51].”
BackgroundZimmerman, M., Young, D., Chelminski, I., Dalrymple, K. L., & Galione, J. N. (2011) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2011.03.004 · Cited by 22
“These findings are not altogether surprising because prior studies of a variety of diagnoses have found elevated levels of anxiety and depressive symptoms and disorders [17-33].”
ResultPrisciandaro, J. J., McRae‐Clark, A. L., Maria, M. M. M., Hartwell, K. J., & Brady, K. T. (2011) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2010.11.028 · Cited by 21
“These numbers are especially concerning because cocaine use is consistently associated with substantially increased mortality (SAMHSA, 2010), psychiatric illness (Conway et al., 2006), functional impairment (Lozano et al.”
Gamble, S. A., Talbot, N. L., Cashman‐Brown, S., He, H., Poleshuck, E. L., Connors, G. J., & Conner, K. R. (2012) · Substance Abuse · doi:10.1080/08897077.2012.746950 · Cited by 22
Longitudinal Determinants of Substance Use Disorders
Brook, J. S., Lee, J. Y., Rubenstone, E., Finch, S. J., Seltzer, N., & Brook, D. W. (2013) · Journal of Urban Health · doi:10.1007/s11524-013-9827-6 · Cited by 23
Trape, S., Charles‐Nicolas, A., Jehel, L., & Lacoste, J. (2014) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000000003 · Cited by 25
“Among patients suffering from cocaine use disorder, 30% to 60% have a co-occurring mental disorder, mostly mood and anxiety disorders (Conway et al., 2006), and past or current attention deficit hyperactivity disorder (Delavenne et al., 2011).”
BackgroundAlcohol use in South Sudan in relation to social factors, mental distress and traumatic events
Lien, L., Hauff, E., Martínez, P., Eide, A. H., Swarts, L., & Ayazi, T. (2016) · BMC Public Health · doi:10.1186/s12889-016-3605-9 · Cited by 23
“First, both exposure to traumatic events and subsequent mental health problems are each associated with alcohol use problems, with alcohol used as a form of self-medication to alleviate symptoms of these disorders [14–16].”
BackgroundGraham-LoPresti, J. R., Gautier, S. W., Sorenson, S. M., & Hayes‐Skelton, S. A. (2017) · Cognitive and Behavioral Practice · doi:10.1016/j.cbpra.2016.12.003 · Cited by 20
Labrum, T., & Solomon, P. (2017) · Psychiatric Quarterly · doi:10.1007/s11126-017-9513-z · Cited by 18
Aquino, J. P. D., Sofuoglu, M., Stefanovics, E. A., & Rosenheck, R. A. (2019) · The American Journal of Drug and Alcohol Abuse · doi:10.1080/00952990.2019.1607363 · Cited by 23
Naturalistic exploratory study of the associations of substance use on ADHD outcomes and function
MacDonald, B., & Sadek, J. R. (2021) · BMC Psychiatry · doi:10.1186/s12888-021-03263-6 · Cited by 24
Metadata
- Authors
- Conway, K. P., Compton, W., Stinson, F. S., & Grant, B. F.
- Affiliations
- National Institutes of Health (US)
- Venue
- The Journal of Clinical Psychiatry
- Publisher
- Physicians Postgraduate Press, Inc
- Published
- 2006-02-15
- Volume
- 67
- Issue
- 02
- Pages
- 247-258
- ISSN
- 0160-6689 (ISSN-L)
- OpenAlex
- W2059057223
- Cited by
- 934
- References
- 24
- Citations by year
- 2026: 25 · 2025: 42 · 2024: 44 · 2023: 35 · 2022: 56 · 2021: 56 · 2020: 83 · 2019: 38 · 2018: 51 · 2017: 55 · 2016: 53 · 2015: 63 · 2014: 55 · 2013: 56 · 2012: 45
- FWCI
- 24.48
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Keywords
- psychiatric comorbidity, mood disorders, anxiety disorders, drug use disorders, substance dependence, substance abuse, lifetime prevalence, sex differences, DSM-IV, illicit drug use
- MeSH terms
- Adolescent, Adult, Alcoholism, Anxiety Disorders, Depressive Disorder, Female, Health Surveys, Humans, Male, Psychiatric Status Rating Scales, Regression Analysis, Sex Factors, United States, Comorbidity, Prevalence, Diagnosis, Dual (Psychiatry), Mood Disorders, Substance-Related Disorders, Diagnostic and Statistical Manual of Mental Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.